USD 2101.5 million
Assisted Reproductive Technology Market Size, Share, Growth Analysis, By Product(Instrument, Accessory & Disposable and Reagents & Media), By Technology(In Vitro-Fertilization, Artificial Insemination and Others), By End User(Fertility Clinic, Hospital, Surgical Center and Clinical Research Institute), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35G2228 |
Region:
Global |
Published Date: July, 2024
Pages:
165
|Tables:
91
|Figures:
76
Assisted Reproductive Technology Market Insights
Global Assisted Reproductive Technology Market size was valued at USD 25.30 Billion in 2022 poised to grow from USD 26.67 Billion in 2023 to USD 40.67 Billion by 2031, growing at a CAGR of 5.40% in the forecast period (2024-2031).
Assisted Reproductive Technology (ART) helps single persons or couples conceive through the application of medical practices and methods. These technologies are aimed at helping those unable to conceive naturally or need additional assistance in fertility combating different impediments and challenges. Assisted reproductive technologies (ART) are a wide-ranging term for several treatments including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), gamete intrafallopian transfer (GIFT), zygote intrafallopian transfer (ZIFT), and gestational surrogacy. These techniques involve the handling of human sperm, eggs and embryos in vitro, leading to the insertion of such embryos into a woman’s uterus or fallopian tube.
The prevalence of infertility is rising, funding for infertility services is coming from both private and public organizations, awareness of infertility treatment and surrogacy is growing, and technological advancements in assisted reproductive technology are the main factors driving the growth of the global market for these services. The World Health Organization (WHO) estimates that 48 million couples and 186 million individuals will receive an infertility diagnosis in 2020. The Centres for Disease Control and Prevention (CDC) estimate that 6% to 12% of American women with PCOS also had an infertility diagnosis. Consequently, rising PCOS incidence raises the risk of infertility and propels the market for assisted reproductive technologies.
US Assisted Reproductive Technology Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
In Vitro Fertilization (IVF)
Fastest Growth
In Vitro Fertilization (IVF)
Growth Rate
19.3% CAGR
Global Assisted Reproductive Technology Market ($ Bn)
Country Share by North America (%)
To get more reports on the above market click here to Buy The Report
Assisted Reproductive Technology Market Segmental Analysis
The global assisted reproductive technology market is segmented based on Product, Technology, End User and Region. In terms of Product, the market is trifurcated into Instrument, Accessory & Disposable and Reagents & Media. Based on the Technology, the market is grouped into In Vitro-Fertilization, Artificial Insemination and Others. Based on the End User, the market is grouped into Fertility Clinic, Hospital, Surgical Center and Clinical Research Institute. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Central & South America and Middle East & Africa.
Analysis by Product
As per categorization by product, the market is classified as instrument, accessory & disposable and reagents & media. Among these, accessory & disposable earned the largest share and continues to dominate the market. Innovations in accessory & disposable are propelling a substantial growth in the global assisted reproductive technology market. High success rates and patient safety are guaranteed by advanced disposables, including culture media and embryo transfer kits. Their supremacy is a result of their vital function in preserving sterility and improving procedural accuracy, which produces better results.
In the global ART market, it is anticipated that instrument category will grow at the fastest pace due to advancements in precision apparatus such as incubators and micromanipulation devices. This increase is fueled by their importance in delivering improved clinical outcomes through greater precision, efficacy and ART treatment success rates.
Analysis by Technology
IVF is spearheading the global assisted reproductive technology market because it continues to innovate in genetic screening and embryo culture techniques. Among other infertility treatment methods, IVF remains accepted due to its efficacy record, personalized treatment plans and technological advancements.
The global assisted reproductive technology market is expected to grow fastest at artificial insemination since it is consumer friendly and economical. Improvements in semen analysis and hormone therapy have improved success rates leading to its increasing popularity as a method of treating infertility or extending family planning options.
Global Assisted Reproductive Technology Market By Product (%)
To get detailed analysis on other segments, Request For Free Sample Report
Assisted Reproductive Technology Market Regional Insights
Owing to its massive investments in health care administration, expanding human population and increasing infertility cases, the Asia-Pacific region is the kingpin of the global assisted reproductive technology market. Countries such as China and India are in need of assisted reproductive technologies (ART) because of changing social norms, rising awareness levels and easier access to modern reproductive technology. The region also gains from increased government funding, changing laws and policies, and an increase in fertility clinics providing state-of-the-art care. These elements coming together, combined with enhanced healthcare systems and economic growth, puts Asia-Pacific as a prominent market for ART, spurring its innovation and growth.
In Europe, the marketplace for assisted reproductive technology (ART) is growing faster than anywhere else in the world owing to its robust healthcare system, progressive legislation and high demand for fertility treatment. This region enjoys significant public backing and awareness, huge amounts of research and development as well as sophisticated ART technologies. The market has expanded due to improved access to fertility clinics, supportive laws on ART and insurance cover for such procedures. This demand also arises from Europe’s aging population coupled with increasing infertility rates while technological advancements aimed at personalizing medicine are contributing to rapid growth within this industry.
Global Assisted Reproductive Technology Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Assisted Reproductive Technology Market Dynamics
Drivers
Rising Infertility Rates
- Infertility rates are increasing due to factors such as late childbearing, changes in lifestyle and environmental interactions; hence ART becomes very crucial. More and more couples want to solve their infertility problems, resulting in more demand for these services leading to increased growth of this industry.
Advancements in ART Technologies
- The current advancements in the ART technologies such as improved genetic screening, embryo culture methods and diagnostic instruments have been raising the efficacy and success rates of therapies. Due to these developments, this industry is progressing due to more patients seeking reliable and effective reproductive health care.
Restraints
High Costs on Access to Assisted Reproductive Technology
- For numerous sufferers, a significant hindrance could be the exorbitant expenses of assisted reproductive technologies (ART), including in vitro fertilization (IVF) and relevant therapies. These expensive methods would restrict access and affordability, thereby inhibiting the growth of their market particularly in regions with weak healthcare support.
Regulatory and Ethical Challenges Impeding Growth
- There are several obstacles and challenges which may hinder the growth of this market including stringent legal restrictions and ethical issues concerning assisted reproductive technologies (ART) such as genetic manipulation and embryo disposal. Furthermore, national regulations variances together with current debates regarding the morality of some ART procedures could impede progress in the industry and innovation.
Request Free Customization of this report to help us to meet your business objectives.
Assisted Reproductive Technology Market Competitive Landscape
Global aided reproductive technology (ART) market is highly competitive as major companies pursue innovative solutions through advanced technologies. Key players include CooperSurgical who offers a variety of ART products, IVF Technologies which was the first to develop ART techniques and Ferring Pharmaceuticals widely recognized for its fertility drugs. To improve success rates and meet increasing demand for ART worldwide, these companies are engaged in R&D activities, forming alliances and expanding their services.
Assisted Reproductive Technology Market Top Players Company Profiles
- Ferring Pharmaceuticals (Switzerland)
- CooperSurgical, Inc. (US)
- IVF Technologies (USA)
- Merck KGaA (Germany)
- Genea Biomedx (Australia)
- Hamilton Thorne Ltd. (Canada)
- Vitrolife AB (Sweden)
- LABORIE (Canada)
- ESN (France)
- MedTec (USA)
- CryoLife, Inc. (USA)
- Nantong Egens Biotechnology Co., Ltd. (China)
- Research Instruments Ltd. (UK)
- Sartorius AG (Germany)
- Thermo Fisher Scientific Inc. (USA)
Assisted Reproductive Technology Market Recent Development
- In June 2024, A novel ovarian stimulation drug with the potential to improve egg quality and increase the success rate of in vitro fertilization (IVF), EndoStim-X was launched by Ferring Pharmaceuticals (Switzerland). Such advances indicate Ferring’s commitment to ART innovation and an effort to develop better treatment options for patients undergoing assisted reproduction.
- In July 2024, Hamilton Thorne Ltd. (Canada) is a company that introduced EmbryoView Pro, a state-of-the-art embryo monitoring technology. This modern system combines AI-based analysis for instant embryo evaluation and thus helps increase precision and enhance ART outcomes. This was in line with Hamilton Thorne’s intent to use technology to advance reproductive medicine.
- In August 2024, A new embryo culture medium called VitroEnhance was introduced by Vitrolife AB (Sweden). With the help of this medium, implantation success rates will rise, and embryo development will be optimised. With constant innovation in reproductive technology and research, Vitrolife is striving to improve the success of ART, as seen by its most recent offering.
Assisted Reproductive Technology Key Market Trends
- Expansion of Personalized ART Solutions: Due to advancements made in genetic screening and embryo analysis, the market is increasingly tilting in favor of individualized ART therapies. These tailored approaches aim at enhancing success rates and producing more efficient and focused fertility treatments by tackling the causes of infertility and considering individual patient concerns.
- Growth in Adoption of Advanced Embryo Monitoring Technologies: Mostly the employ of sophisticated embryo screening instruments has increased significantly; including systems that utilize artificial intelligence (AI), as well as new age imaging machines and techniques. Such advances are responsible for better success rates in the assisted reproductive technology (ART) area owing to their contributions towards improving embryonic evaluation precision alongside refining the mode of selecting one from another.
Assisted Reproductive Technology Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, Rising infertility rates, technological breakthroughs, and growing public awareness are driving the dynamic expansion of the global assisted reproductive technology market. However, there are still challenges such as high costs and bureaucracy. But this progress in treatment efficiency and rates of success is attributed to progress on personalized ART protocols besides advanced embryo- monitoring technologies.
Important companies, such as Hamilton Thorne Ltd. and Ferring Pharmaceuticals, are advancing the field significantly with new products like EmbryoView Pro and EndoStim-X. Leaders in the region, especially in Asia-Pacific and Europe, are taking advantage of the robust healthcare system and changing demand to shape the future of ART through sustained innovation and growth.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 25.30 Billion |
| Market size value in 2031 | USD 40.67 Billion |
| Growth Rate | 5.40% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Assisted Reproductive Technology Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Assisted Reproductive Technology Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Assisted Reproductive Technology Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Assisted Reproductive Technology Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Assisted Reproductive Technology Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Assisted Reproductive Technology Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
